Sacks, Frank M.
Researcher in Department of Nutrition, Harvard School of Public Health, Boston, USA.
Channing Laboratory and Cardiology Division, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, USA.
Channing Laboratory and Cardiology Division, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, USA.
Áreas de investigación
Enfoque geográfico
- United States of America Autogobierno
- Afiliación
- Publicaciones
- Contacto
- Otro
- Ver todos
Afiliación
Publicaciones
publicaciones seleccionadas
-
artículo académico
- Snake venomics of the pit vipers Porthidium nasutum, Porthidium ophryomegas, and Cerrophidion godmani from Costa Rica: Toxicological and taxonomical insights. Journal of Proteomics. 75:1675-1689. 2012
- Dietary interventions that lower lipoproteins containing apolipoprotein C-III are more effective in whites than in blacks: results of the OmniHeart trial. The American Journal of Clinical Nutrition. 92:714-722. 2010
- Dietary therapy in hypertension. The New England Journal of Medicine. 362:2102-2112. 2010
- Effect of pravastatin therapy on coronary events in carriers of the KIF6 719Arg allele from the cholesterol and recurrent events trial. The American Journal of Cardiology. 105:1300-1305. 2010
- Investigation of KIF6 Trp719Arg in a Case-Control Study of Myocardial Infarction: A Costa Rican Population. PLoS ONE. 5. 2010
- Pravastatin Therapy Among All Ethnic Groups of CARE Reduced Primary End Point Events in Carriers of the KIF6 719Arg Allele, but not in Noncarriers. Journal of the American College of Cardiology. 55:A130-E1219. 2010
- Abdominal obesity and hyperglycemia mask the effect of a common APOC3 haplotype on the risk of myocardial infarction. The American Journal of Clinical Nutrition. 87:1932-1938. 2008
- Association Between ADAMTS1 Matrix Metalloproteinase Gene Variation, Coronary Heart Disease, and Benefit of Statin Therapy. Arteriosclerosis, Thrombosis, and Vascular Biology. 28:562-567. 2008
- Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials. Journal of the American College of Cardiology. 51:435-443. 2008
- Effect of protein, unsaturated fat, and carbohydrate intakes on plasma apolipoprotein B and VLDL and LDL containing apolipoprotein C-III: results from the OmniHeart Trial. The American Journal of Clinical Nutrition. 87:1623-1630. 2008
- Asp92Asn polymorphism in the myeloid IgA Fc receptor is associated with myocardial infarction in two disparate populations: CARE and WOSCOPS. Arteriosclerosis, Thrombosis, and Vascular Biology. 26:2763-2768. 2006
- Polyunsaturated fatty acids, inflammation, and cardiovascular disease: time to widen our view of the mechanisms. Isolation from a polyvalent antivenom of antibodies to a myotoxin in Bothrops asper snake venom. 91:398-400. 2006
- Diurnal and acute patterns of postprandial apolipoprotein B-48 in VLDL, IDL, and LDL from normolipidemic humans. Atherosclerosis. 181:345-351. 2005
- Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in very low density, low density, and high density lipoproteins in surgically postmenopausal women. Isolation from a polyvalent antivenom of antibodies to a myotoxin in Bothrops asper snake venom. 89:2207-2213. 2004
- Hypertriglyceridemia but not diabetes status is associated with VLDL containing apolipoprotein CIII in patients with coronary heart disease. Atherosclerosis. 167:293-302. 2003
- LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients. Arteriosclerosis, Thrombosis, and Vascular Biology. 23:853-858. 2003
- Low-density lipoprotein size and cardiovascular disease: a reappraisal. Isolation from a polyvalent antivenom of antibodies to a myotoxin in Bothrops asper snake venom. 88:4525-4532. 2003
- Is the Size of Low-Density Lipoprotein Particles Related to the Risk of Coronary Heart Disease?—Reply. JAMA Internal Medicine. 287:712-713. 2002
- AHA scientific statement: summary of the scientific conference on dietary fatty acids and cardiovascular health: conference summary from the nutrition committee of the American Heart Association. The Journal of Nutrition. 131:1322-1326. 2001
- Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia. Journal of Lipid Research. 42:1239-1249. 2001
- Ent-Clerodane derivatives from Chromolaena connivens. JAMA Internal Medicine. 28:1468-1474. 2001
- Summary of the scientific conference on dietary fatty acids and cardiovascular health: conference summary from the nutrition committee of the American Heart Association. Circulation. 103:1034-1039. 2001
- Distinct patterns of apo B lipoproteins defined by apo CIII or E in hyperlipidemias. Atherosclerosis. 151:172-172. 2000
- Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and C-III content. Journal of Lipid Research. 40:202-212. 1999
- Metabolism of Apo (a) and ApoB100 of lipoprotein (a) in women: effect of postmenopausal estrogen replacement. Isolation from a polyvalent antivenom of antibodies to a myotoxin in Bothrops asper snake venom. 83:3267-3276. 1998
- Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. Isolation from a polyvalent antivenom of antibodies to a myotoxin in Bothrops asper snake venom. 82:3955-3963. 1997
- Differential effects of estrogen on low-density lipoprotein subclasses in healthy postmenopausal women. Metabolism Clinical and Experimental. 42:1153-1158. 1993
Contacto
nombre completo
- Frank M. Sacks
Otro
Fecha / hora
- mayo 1, 2014